| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |